Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects

被引:112
作者
Doose, DR
Wang, SS
Padmanabhan, M
Schwabe, S
Jacobs, D
Bialer, T
机构
[1] Hebrew Univ Jerusalem, Dept Pharmaceut, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel
[3] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA
关键词
topiramate; carbamazepine; ethinyl estradiol; norethidrone; obesity;
D O I
10.1046/j.1528-1157.2003.55602.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To study the pharmacokinetics of a combination oral contraceptive (OC) containing norethindrone and ethinyl estradiol during OC monotherapy, concomitant OC and topiramate (TPM) therapy, and concomitant OC and carbamazepine (CBZ) therapy in order to comparatively evaluate the pharmacokinetic interaction, which may cause contraceptive failure. Methods: This randomized, open-label, five-group study included two 28-day cycles. Five groups of female subjects received oral doses of ORTHO-NOVUM 1/35 alone (cycle 1) and then concomitant with TPM or CBZ (cycle 2). The treatment groups were group 1, TPM, 50 mg/day; group 2, TPM, 100 mg/day; group 3, TPM, 200 mg/day; group 4, TPM, 200 mg/day (obese women); and group 5, CBZ, 600 mg/day. Group 4 comprised obese women whose body mass index (BMI) was between 30 and 35 kg/m(2). The BMI of the remaining four groups was less than or equal to27 kg/m(2). Results: Coadministration of TPM at daily doses of 50, 100, and 200 mg (nonobese) and 200 mg (obese) nonsignificantly (p > 0.05) changed the mean area under the curve (AUC) of ethinyl estradiol by -12%, +5%, -11%, and -9%, respectively, compared with OC monotherapy. A similar nonsignificant difference was observed with the plasma levels and AUC values of norethindrone (p > 0.05). CBZ (600 mg/day) significantly (p < 0.05) decreased the AUC values of norethindrone and ethinyl estradiol by 58% and 42%, respectively, and increased their respective oral clearance by 69% and 127% (p < 0.05). Because CBZ induces CYP 3A-mediated and glucuronide conjugation metabolic pathways, the significant increase in the oral clearance of ethinyl estradiol and norethindrone was anticipated. Conclusions: TPM, at daily doses of 50-200 mg, does not interact with an OC containing norethindrone and ethinyl estradiol. The lack of the TPM-OC interaction is notable when it is compared with the CBZ-OC interaction.
引用
收藏
页码:540 / 549
页数:10
相关论文
共 23 条
[1]   THE GUT WALL METABOLISM OF ETHINYLESTRADIOL AND ITS CONTRIBUTION TO THE PRE-SYSTEMIC METABOLISM OF ETHINYLESTRADIOL IN HUMANS [J].
BACK, DJ ;
BRECKENRIDGE, AM ;
MACIVER, M ;
ORME, M ;
PURBA, HS ;
ROWE, PH ;
TAYLOR, I .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (03) :325-330
[2]   A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers [J].
Bartoli, A ;
Gatti, G ;
Cipolla, G ;
Barzaghi, N ;
Veliz, G ;
Fattore, C ;
Mumford, J ;
Perucca, E .
EPILEPSIA, 1997, 38 (06) :702-707
[3]   Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI) [J].
Bialer, M ;
Johannessen, SI ;
Kupferberg, HJ ;
Levy, RH ;
Loiseau, P ;
Perucca, E .
EPILEPSY RESEARCH, 2002, 51 (1-2) :31-71
[4]   Pharmacotherapeutic issues for women of childbearing age with epilepsy [J].
Chang, SI ;
McAuley, JW .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (7-8) :794-801
[5]   DO ANTICONVULSANTS REDUCE THE EFFICACY OF ORAL-CONTRACEPTIVES [J].
COULAM, CB ;
ANNEGERS, JF .
EPILEPSIA, 1979, 20 (05) :519-525
[6]   THE LACK OF EFFECT OF SODIUM VALPROATE ON THE PHARMACOKINETICS OF ORAL-CONTRACEPTIVE STEROIDS [J].
CRAWFORD, P ;
CHADWICK, D ;
CLELAND, P ;
TJIA, J ;
COWIE, A ;
BACK, DJ ;
ORME, ML .
CONTRACEPTION, 1986, 33 (01) :23-29
[7]   Interactions between antiepileptic drugs and hormonal contraception [J].
Crawford, P .
CNS DRUGS, 2002, 16 (04) :263-272
[8]   THE INTERACTION OF PHENYTOIN AND CARBAMAZEPINE WITH COMBINED ORAL-CONTRACEPTIVE STEROIDS [J].
CRAWFORD, P ;
CHADWICK, DJ ;
MARTIN, C ;
TJIA, J ;
BACK, DJ ;
ORME, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (06) :892-896
[9]  
DOOSE D, 2002, EPILIPSIA, V43, P146
[10]  
Doose Dennis R., 2002, Epilepsia, V43, P205